CLDN18: Clinical, Pathological, and Genetic Signatures with Drug Screening in Gastric Adenocarcinoma. Hur JY, Min KW, Noh YK, Won YW, Yeo Y, Kim DH, Son BK, Kwon MJ, Pyo JS. Curr Med Chem. 2025;32(12):2409-2421.
p27 Cell Cycle Inhibitor and Survival in Luminal-Type Breast Cancer: Gene Ontology, Machine Learning, and Drug Screening Analysis. Park IA, Noh YK, Min KW, Kim DH, Lee JY, Son BK, Kwon MJ, Han MH, Hur JY, Pyo JS. J Breast Cancer. 2024 Oct;27(5):305-322.
Significant Genes Associated with Mortality and Disease Progression in Grade II and III Glioma. Choi BM, Cheong JH, Ryu JI, Won YD, Min KW, Han MH. Biomedicines. 2024 Apr 12;12(4):858.
JAK2 Loss Arising From Tumor-Spread-Through-Air-Spaces (STAS) Promotes Tumor Progression by Suppressing CD8+ T Cells in Lung Adenocarcinoma: A Machine Learning Approach. Choi S, Kim HS, Min KW, Noh YK, Lee JY, Moon JY, Jung US, Kwon MJ, Kim DH, Son BK, Pyo JS, Ro SK. J Korean Med Sci. 2024 Jan 15;39(2):e16.
Cancer-Associated Fibroblasts Together with a Decline in CD8+ T Cells Predict a Worse Prognosis for Breast Cancer Patients. Kim HS, Noh YK, Min KW, Kim DH, Kwon MJ, Pyo JS, Lee JY. Ann Surg Oncol. 2024 Mar;31(3):2114-2126.